--- title: "Neuralink revenue and valuation" description: "Neuralink's revenue is estimated at $115M–$330M. Valued at $9.65B after raising $1.34B. Funding rounds and competitors." url: https://www.tryspecter.com/revenue-valuation/neuralink.md canonical_url: https://www.tryspecter.com/revenue-valuation/neuralink publisher: Specter last_updated: 2026-11-01 --- # Neuralink revenue and valuation Specter estimates Neuralink's annual revenue at $115M to $330M and its valuation at $5.28B to $14.6B. The company was priced at $9.65B in May 2025. Neuralink develops implantable brain-computer interfaces. - Estimated revenue: $115M to $330M (October 2026) - Estimated valuation: $5.28B to $14.6B (October 2026) - Total funding: $1.34B - Founded: 2016 - Headquarters: Austin, United States - Employees: 705 - Sector: Neurotech - Specter Rank: #41,948 ## Neuralink revenue Specter's model puts current revenue between $115M and $330M. | Month | Specter estimate | Low | High | | --- | --- | --- | --- | | October 2026 | $220M | $115M | $330M | | September 2026 | $107M | $56M | $159M | | August 2026 | $155M | $78M | $230M | | July 2026 | $155M | $79M | $230M | | June 2026 | $210M | $76M | $340M | | May 2026 | $197M | $68M | $330M | | April 2026 | $167M | $67M | $270M | | March 2026 | $149M | $66M | $230M | | February 2026 | $156M | $69M | $240M | | January 2026 | $148M | $61M | $240M | | December 2025 | $151M | $67M | $240M | | November 2025 | $139M | $50M | $230M | | October 2025 | $142M | $51M | $230M | | September 2025 | $137M | $47M | $230M | | August 2025 | $148M | $51M | $250M | | July 2025 | $149M | $53M | $250M | | June 2025 | $154M | $51M | $260M | | May 2025 | $150M | $51M | $250M | | April 2025 | $148M | $50M | $250M | | March 2025 | $145M | $52M | $240M | | February 2025 | $146M | $53M | $240M | | January 2025 | $146M | $55M | $240M | | December 2024 | $151M | $56M | $250M | | November 2024 | $151M | $59M | $240M | | October 2024 | $136M | $50M | $220M | | September 2024 | $141M | $56M | $230M | | August 2024 | $109M | $43M | $174M | | July 2024 | $119M | $43M | $194M | | June 2024 | $116M | $45M | $187M | ## Neuralink valuation Neuralink's valuation rose from $2B at its Series C in July 2021 to $9.65B at its Series E in May 2025. Specter's live estimate sits between $5.28B and $14.6B. | Month | Specter estimate | Low | High | | --- | --- | --- | --- | | October 2026 | $8.79B | $5.28B | $14.6B | | September 2026 | $8.52B | $4.95B | $14.7B | | August 2026 | $8.31B | $5.03B | $13.7B | | July 2026 | $8.6B | $5.56B | $13.3B | | June 2026 | $9.45B | $6.57B | $13.6B | | May 2026 | $9.3B | $6.66B | $13B | | April 2026 | $8.45B | $5.68B | $12.6B | | March 2026 | $8.51B | $5.67B | $12.8B | | February 2026 | $8.62B | $6.07B | $12.3B | | January 2026 | $8.7B | $6.33B | $11.9B | | December 2025 | $8.8B | $6.7B | $11.6B | | November 2025 | $8.81B | $6.54B | $11.9B | | October 2025 | $8.96B | $7.02B | $11.4B | | September 2025 | $8.97B | $7.25B | $11.1B | | August 2025 | $9B | $7.49B | $10.8B | | July 2025 | $9B | $7.31B | $11.1B | | June 2025 | $9B | $7.49B | $10.8B | | May 2025 | $9.65B | $8.03B | $11.6B | | April 2025 | $8.5B | $7.07B | $10.2B | | March 2025 | $8.52B | $5.17B | $14.1B | | February 2025 | $8.55B | $5.32B | $13.7B | | January 2025 | $8.57B | $5.4B | $13.6B | | December 2024 | $8.59B | $5.38B | $13.7B | | November 2024 | $8.62B | $5.79B | $12.8B | | October 2024 | $8.64B | $5.49B | $13.6B | | September 2024 | $8.66B | $5.54B | $13.6B | | August 2024 | $8.69B | $4.76B | $15.9B | | July 2024 | $8.71B | $5.98B | $12.7B | | June 2024 | $8.73B | $5.73B | $13.3B | | Reported valuation | Month | Source | | --- | --- | --- | | $9B | August 2025 | [dev.ua](https://dev.ua/news/neuralink-maska-rozpochala-vyprobuvannia-mozkovykh-implantiv-u-brytanii-1754055141) | | $9B | June 2025 | [timesofindia.indiatimes.com](https://timesofindia.indiatimes.com/technology/tech-news/elon-musks-brain-chip-startup-neuralink-raises-650-million-in-series-e-round/articleshow/121587635.cms) | | $9.65B | May 2025 | Funding round | | $8.5B | April 2025 | [forbes.ge](https://forbes.ge/ilon-maskis-neuralink-is-ghirebuleba-shesadzloa-8-5-miliardad-shephasdes/) | | $9B | July 2023 | [techcrunch.com](https://www.techcrunch.com/latest/elon-musks-neuralink-raises-600m-at-9b-valuation/) | | $5B | June 2023 | Funding round | | $2B | July 2021 | Funding round | ## Neuralink funding rounds | Date | Round | Raised | Post-money | Lead investors | | --- | --- | --- | --- | --- | | 6 May 2026 | Venture round | Undisclosed | Undisclosed | Oman Investment Authority | | 7 Jul 2025 | Venture round | Undisclosed | Undisclosed | CoreNest Capital | | 17 Jun 2025 | Secondary | Undisclosed | Undisclosed | Undisclosed | | 27 May 2025 | Series E | $649M | $9.65B | Undisclosed | | 9 May 2024 | Secondary | Undisclosed | Undisclosed | Undisclosed | | 7 Aug 2023 | Series D | $323M | Undisclosed | Founders Fund | | 5 Jun 2023 | Secondary | Undisclosed | $5B | Undisclosed | | 7 Dec 2021 | Secondary | Undisclosed | Undisclosed | Undisclosed | | 29 Jul 2021 | Series C | $205M | $2B | Vy Capital | | 29 Apr 2019 | Series B | $51M | Undisclosed | Undisclosed | | 25 Aug 2017 | Series A | $107M | Undisclosed | Undisclosed | ## Neuralink vs competitors The brain-computer interface market splits between high-bandwidth invasive implants and safety-focused minimally invasive devices. | Company | Estimated revenue | Estimated valuation | | --- | --- | --- | | Neuralink | $115M–$330M | $5.28B–$14.6B | | Synchron (synchron.com) | $7.4M–$50M | $750M–$1.6B | | Blackrock Neurotech (blackrockneurotech.com) | $9.8M–$30M | $35M–$210M | | Precision Neuroscience (precisionneuro.io) | $3.6M–$42M | $880M–$1.28B | | Science (science.xyz) | $15M–$87M | $1.22B–$1.78B | ## Questions ### What is Neuralink's revenue? Specter estimates Neuralink's annual revenue at $115M to $330M as of October 2026. ### What is Neuralink's valuation? Neuralink's latest post-money valuation is $9.65B, from a May 2025 Series E. Specter's live estimate is $5.28B to $14.6B. ### How much funding has Neuralink raised? $1.34B across 11 rounds, from a $107M Series A in August 2017 to a venture round in May 2026. ### Who invested in Neuralink? 47 investors, including CoreNest Capital, Founders Fund, Oman Investment Authority and Vy Capital. ### Who are Neuralink's competitors? Synchron, Blackrock Neurotech, Precision Neuroscience and Science. Specter ranks 30 competitors for Neuralink. ## About this data Specter models revenue and valuation monthly and anchors each estimate to reported figures and priced rounds. Method: https://www.tryspecter.com/revenue-valuation Cite as: Specter. "Neuralink revenue and valuation." tryspecter.com/revenue-valuation/neuralink. Updated November 2026.